TGNA
48
-5
DFS
65
-5
CRM
64
-3
AVGO
81
-2
MAT
42
-3
SJM
19
-2
T
33
-3
TXN
33
-2
EFX
41
-2
ICE
55
-2
PNR
59
-3
CMG
58
-5
MMM
35
-5
UPS
51
-2
WFC
58
-2
EXPE
83
-5
CHD
34
-5
BK
61
-4
ORCL
51
-4
XRAY
31
-3
TGNA
48
-5
DFS
65
-5
CRM
64
-3
AVGO
81
-2
MAT
42
-3
SJM
19
-2
T
33
-3
TXN
33
-2
EFX
41
-2
ICE
55
-2
PNR
59
-3
CMG
58
-5
MMM
35
-5
UPS
51
-2
WFC
58
-2
EXPE
83
-5
CHD
34
-5
BK
61
-4
ORCL
51
-4
XRAY
31
-3
Financhill
Back

Sarepta Therapeutics Vs. Summit Therapeutics Industry Stock Comparison

Sell
42

SRPT
Sarepta Therapeutics

Last Price:
$119.85
Seasonality Move:
9.24%
Sell
34

SMMT
Summit Therapeutics

Last Price:
$17.85
Seasonality Move:
13.77%
Sell
42
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $121.50. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Summit Therapeutics (SMMT) is a Sell

Is Summit Therapeutics a Buy, Sell or Hold?

  • The current Summit Therapeutics [SMMT] share price is $18.21. The Score for SMMT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • SMMT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $121.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

SMMT Stock Price Chart

What is Summit Therapeutics's stock price today?

  • The Summit Therapeutics share price today is $18.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 47.71 Sell
Chaikin Money Flow: -244699 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (118.28 - 130.04) Sell
Bollinger Bands (100): (118.1 - 134.36) Sell

SMMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 47.51 Sell
Chaikin Money Flow: -1110770 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.82 - 18.98) Sell
Bollinger Bands (100): (14.19 - 22.73) Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 121.49 Buy
20-day SMA: 124.81 Sell
50-day SMA: 122.83 Sell
200-day SMA: 129.64 Sell
8-day EMA: 122.13 Sell
20-day EMA: 122.75 Sell
50-day EMA: 123.43 Sell
200-day EMA: 125.83 Sell

SMMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.37 Sell
20-day SMA: 18.26 Sell
50-day SMA: 19.36 Sell
200-day SMA: 12.33 Buy
8-day EMA: 18.5 Sell
20-day EMA: 18.52 Sell
50-day EMA: 18.73 Sell
200-day EMA: 13.86 Buy

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.75 per share, and an increase next year of $7.84 per share.

Summit Therapeutics Earnings Growth & SMMT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and a decrease next year of $0.08 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Summit Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):